Lakefront Biotherapeutics NV (LKFT)
NASDAQ: LKFT · Real-Time Price · USD
34.33
-0.06 (-0.17%)
Nov 18, 2026, 1:04 PM EST - Market open
Lakefront Biotherapeutics NV Employees
Lakefront Biotherapeutics NV had 196 employees as of June 30, 2026. The number of employees decreased by 256 or 56.64% since the number was reported on December 31, 2025.
Employees
196
Change
-256
Growth
-56.64%
Revenue / Employee
$5,773,962
Profits / Employee
$3,477,735
Market Cap
2.21B
Employees Chart
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 196 | -256 | -56.64% |
| Dec 31, 2025 | 452 | -252 | -35.80% |
| Dec 31, 2024 | 704 | -419 | -37.31% |
| Dec 31, 2023 | 1,123 | -215 | -16.07% |
| Dec 31, 2022 | 1,338 | 29 | 2.22% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Arcus Biosciences | 601 |
| Beam Therapeutics | 557 |
| Harmony Biosciences Holdings | 293 |
| Biohaven | 274 |
| Immunome | 267 |
| Celldex Therapeutics | 198 |
| Pharvaris | 148 |
| Aurinia Pharmaceuticals | 128 |
LKFT News
- 1 day ago - Lakefront Biotherapeutics NV Transcript: Jefferies Global Healthcare Conference - Transcripts
- 2 days ago - Lakefront Biotherapeutics price target raised to $27 from $26 at Morgan Stanley - TheFly
- 2 days ago - Lakefront Biotherapeutics initiates EUR 50M share repurchase program - TheFly
- 2 days ago - Lakefront Initiates New €50 Million Share Repurchase Program Following Completion of Initial Share Repurchase Program - GlobeNewsWire
- 5 days ago - Lakefront Biotherapeutics NV Earnings release: Q3 2026 - Filings
- 5 days ago - Lakefront Biotherapeutics NV Earnings release: Q3 2026 - Filings
- 5 days ago - Galapagos NV Reports Nine Months 2026 Financial Results and Announces Second €50 million Share Repurchase Program - Nasdaq
- 6 days ago - Lakefront Biotherapeutics Reports Nine Months 2026 Financial Results and Provides Business Update - GlobeNewsWire